hOKT3gamma1 (Ala-Ala) for the Treatment of Psoriatic Arthritis - No Study Results Posted

hOKT3gamma1 (Ala-Ala) for the Treatment of Psoriatic Arthritis (PART)

This study has been suspended.

( FDA Clinical Hold )

Study NCT00239720 Information provided by National Institute of Allergy and Infectious Diseases (NIAID)

First Received: October 13, 2005 Last Updated: May 13, 2009 History of Changes

No Study Results Posted for this Study

Study Status:	This study has been suspended.
Estimated Study Completion Date:	January 2011
Estimated Primary Completion Date:	July 2010 (Final data collection date for primary outcome measure)